Request Demo
Last update 16 Sep 2026
Suzhou Baimai Biopharmaceutical Co. Ltd.
Last update 16 Sep 2026
Overview
Tags
Neoplasms
Eye Diseases
Digestive System Disorders
Biological products
Antibody
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
ChiCTR2200064999
A single-arm, single-center clinical study on the safety, tolerability and anti-tumor effect of BM601 for TACE in the treatment of hepatocellular carcinoma
ChiCTR2100050327
Phase 0 open, single-center clinical study to evaluate the safety, tolerability and anti-tumor effects of JN101 injection combined with radiotherapy in patients with malignant solid tumors
ChiCTR2100050328
An open, single-center clinical study to evaluate the safety, tolerability and anti-tumor effects of BM201 injection combined with radiotherapy in patients with advanced malignant solid tumors
100 Clinical Results associated with Suzhou Baimai Biopharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Suzhou Baimai Biopharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Baimai Biopharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 27 Sep 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
8
Preclinical
Phase 1
2
3
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free